DescriptionLunginnov s.a.s develops, manufacture and commercialize innovative solutions to study or diagnose endothelial dysfunction (sepsis, cancer, etc…)
1) To develop, produce and commercialize innovative biomarkers (tissue and blood), in order to detect, to study, to diagnose endothelial dysfunction (active, inflammatory or injured) and/or to track changes in treatments.
2) To develop, produce and commercialize reagents (research use only/RUO) products that have been validated by peer-reviewed publications.
Complementary Mission: To develop R&D programs in order to offer new diagnostic and therapeutic solutions targeting the endothelium.
Lunginnov s.a.s offers two ranges of products:
1)Products « for research use only » purposes (antibodies, recombinant proteins, kits / immunoassays…) to study vascular remodeling (cancer, angiogenesis, inflammation, sepsis, obesity…).
2) IVD products including ELISA kits for diagnosis and/or prognosis and/or the follow-up of patients under treatment in domains of sepsis and cancer.
Address : Lunginnov
1, rue du Pr Calmette
Tel : 33 320 877 211
Fax : 33 320 877 884